PT  - JOURNAL ARTICLE
AU  - Grosjean, J.
AU  - Letord, C.
AU  - Zana, I.
AU  - Advenier-Iakovlev, E.
AU  - Duclos, C.
AU  - Krebs, MO.
AU  - Charlet, J.
AU  - Darmoni, SJ.
TI  - Off-label drug database
AID  - 10.1101/2021.11.25.21266864
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.11.25.21266864
4099  - http://medrxiv.org/content/early/2021/11/30/2021.11.25.21266864.short
4100  - http://medrxiv.org/content/early/2021/11/30/2021.11.25.21266864.full
AB  - Background Many drugs are still being prescribed in a “off-label mode” and especially in psychiatry. Off-label prescription situations may vary depending on several factors and such practice is not well identifiable in the literature. Methods: A new public academic drug database has been recently created and is able to contain off-label indications, especially in psychiatry in the context of the PSYHAMM French research project. For each situation, bibliographic references have been collected to make the scientific information available to all. Results: this new off-label drug database contains more than 18,154 lines. It is freely available at https://www.hetop.eu/hetop/medicaments. Several off-label usages have been formally described and the system is extensible to all drugs and all specialties. Conclusion: An off-label drug database can be a valuable tool for health professionals and students.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is partially granted by the French National Research Agency for the PSYHAMM project (https://anr.fr/Projet-ANR-18-CE19-0017).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors